4//SEC Filing
Green Eric Mark 4
Accession 0001127602-24-021894
CIK 0000105770other
Filed
Aug 7, 8:00 PM ET
Accepted
Aug 8, 4:16 PM ET
Size
12.1 KB
Accession
0001127602-24-021894
Insider Transaction Report
Form 4
Green Eric Mark
DirectorPresident, CEO and Board Chair
Transactions
- Exercise/Conversion
Common Stock
2024-08-06$59.64/sh+30,732$1,832,856→ 192,640.125 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-08-06−6,000→ 0 totalExercise: $59.64Exp: 2026-02-23→ Common Stock (6,000 underlying) - Sale
Common Stock
2024-08-06$304.71/sh−30,732$9,364,409→ 161,898.125 total - Exercise/Conversion
Common Stock
2024-08-06$59.64/sh+6,000$357,840→ 167,898.125 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-08-06−30,732→ 6,000 totalExercise: $59.64Exp: 2026-02-23→ Common Stock (30,732 underlying)
Footnotes (3)
- [F1]The shares reported were acquired by the Reporting Person from exercising a portion of a stock option award expiring in 2026, pursuant to Rule 10b5-1 Trading Plan. The purchase and sale reported on this Form 4 was completed pursuant to a Rule 10b5-1 Trading Plan adopted by the Reporting Person on 11/17/2023.
- [F2]The price reported in Column 4 is a weighted average price.
- [F3]This option is fully vested.
Documents
Issuer
WEST PHARMACEUTICAL SERVICES INC
CIK 0000105770
Entity typeother
Related Parties
1- filerCIK 0001336007
Filing Metadata
- Form type
- 4
- Filed
- Aug 7, 8:00 PM ET
- Accepted
- Aug 8, 4:16 PM ET
- Size
- 12.1 KB